Ultravist (Bayer HealthCare Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Ultravist drug offered from Bayer HealthCare Pharmaceuticals Inc.. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Bayer HealthCare Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | iopromide |
SUBSTANCE NAME: | IOPROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
ROUTE: | INTRA-ARTERIAL |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-12-30 |
END MARKETING DATE: | 0000-00-00 |
Ultravist HUMAN PRESCRIPTION DRUG Details:
Item Description | Ultravist from Bayer HealthCare Pharmaceuticals Inc. |
LABELER NAME: | Bayer HealthCare Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 498.72(mg/mL) |
START MARKETING DATE: | 2009-12-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50419-342_2489e7db-08dc-4023-8265-66e0424200ef |
PRODUCT NDC: | 50419-342 |
APPLICATION NUMBER: | NDA021425 |
Other IOPROMIDE Pharmaceutical Manufacturers / Labelers: